A new paper examining recent research and safety data published in the peer-reviewed journal Food Science and Technology Bulletin provides scientific support for Bacillus coagulans as a probiotic. The overview supports the use of probiotics in general and discusses a specific Bacillus coagulans strain, known as GanedenBC30 (Bacillus coagulans GBI-30, 6086), manufactured by consumer healthcare company Ganeden Biotech, for its probiotic attributes. The study summarizes how GanedenBC30 supports its health claims related to safety, gastrointestinal health, immune health, joint health and includes never before published data.